These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35101183)

  • 21. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
    Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK;
    J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial.
    Peirsman EJ; Carvelli TJ; Hage PY; Hanssens LS; Pattyn L; Raes MM; Sauer KA; Vermeulen F; Desager KN
    Pediatr Pulmonol; 2014 Jul; 49(7):624-31. PubMed ID: 24039119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiotherapy breathing retraining for asthma: a randomised controlled trial.
    Bruton A; Lee A; Yardley L; Raftery J; Arden-Close E; Kirby S; Zhu S; Thiruvothiyur M; Webley F; Taylor L; Gibson D; Yao G; Stafford-Watson M; Versnel J; Moore M; George S; Little P; Djukanovic R; Price D; Pavord ID; Holgate ST; Thomas M
    Lancet Respir Med; 2018 Jan; 6(1):19-28. PubMed ID: 29248433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing Asthma in Pregnancy (MAP) trial: FENO levels and childhood asthma.
    Morten M; Collison A; Murphy VE; Barker D; Oldmeadow C; Attia J; Meredith J; Powell H; Robinson PD; Sly PD; Gibson PG; Mattes J
    J Allergy Clin Immunol; 2018 Dec; 142(6):1765-1772.e4. PubMed ID: 29524536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
    Chupp GL; Bradford ES; Albers FC; Bratton DJ; Wang-Jairaj J; Nelsen LM; Trevor JL; Magnan A; Ten Brinke A
    Lancet Respir Med; 2017 May; 5(5):390-400. PubMed ID: 28395936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
    Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Brightling CE; Chanez P; Leigh R; O'Byrne PM; Korn S; She D; May RD; Streicher K; Ranade K; Piper E
    Lancet Respir Med; 2015 Sep; 3(9):692-701. PubMed ID: 26231288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker-guided management reduces exacerbations in non-eosinophilic asthma in pregnancy: A secondary analysis of a randomized controlled trial.
    Murphy VE; Porsbjerg CM; Robijn AL; Gibson PG
    Respirology; 2020 Jul; 25(7):719-725. PubMed ID: 31656059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: A dual centre randomized controlled trial.
    Petsky HL; Li AM; Au CT; Kynaston JA; Turner C; Chang AB
    Pediatr Pulmonol; 2015 Jun; 50(6):535-43. PubMed ID: 24891337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
    Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractional exhaled nitric oxide-guided algorithm for children with asthma.
    Lee QU
    Pediatr Pulmonol; 2015 Sep; 50(9):932-3. PubMed ID: 25327828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.
    Ramsahai JM; Simpson JL; Cook A; Gibson PG; McDonald V; Grainge C; Heaney LG; Wark PA
    Thorax; 2023 Sep; 78(9):868-874. PubMed ID: 36948587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
    Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
    Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial.
    Chan AH; Stewart AW; Harrison J; Camargo CA; Black PN; Mitchell EA
    Lancet Respir Med; 2015 Mar; 3(3):210-9. PubMed ID: 25617215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
    Martinez FD; Chinchilli VM; Morgan WJ; Boehmer SJ; Lemanske RF; Mauger DT; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bade E; Covar RA; Friedman NJ; Guilbert TW; Heidarian-Raissy H; Kelly HW; Malka-Rais J; Mellon MH; Sorkness CA; Taussig L
    Lancet; 2011 Feb; 377(9766):650-7. PubMed ID: 21324520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials.
    Panettieri RA; Sjöbring U; Péterffy A; Wessman P; Bowen K; Piper E; Colice G; Brightling CE
    Lancet Respir Med; 2018 Jul; 6(7):511-525. PubMed ID: 29792288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
    Busse WW; Wenzel SE; Casale TB; FitzGerald JM; Rice MS; Daizadeh N; Deniz Y; Patel N; Harel S; Rowe PJ; Graham NMH; O'Riordan T; Pavord ID
    Lancet Respir Med; 2021 Oct; 9(10):1165-1173. PubMed ID: 34181876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.